Source: Silicon Valley Investclub

TORL: TORL BioTherapeutics Raises $158 Million in Funding

TORL BioTherapeutics is a clinical-stage biotechnology company dedicated to cutting-edge science to address the medical needs of cancer... The post TORL BioTherapeutics Raises $158 Million in Funding first appeared on Silicon Valley Investclub.

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Chairman & CEO

Mark J. Alles

CEO Approval Rating

90/100

TORL is a California-based biotechnology company that researches and develops novel and antibody-based therapeutics for the treatment of cancer.